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of Neutrophil extracellular Traps
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Laboratory of Experimental Thrombosis, Institute of Experimental Medicine-CONICET, National Academy of Medicine, 
Buenos Aires, Argentina
In addition to being key elements in hemostasis and thrombosis, platelets have an import-
ant role in the inflammatory and innate immune response. This activity is associated with 
their capability to recognize pathogens through the expression of toll-like receptors, the 
secretion of various cytokines, chemokines, and growth factors stored within their gran-
ules, and the expression of cell adhesion molecules that allows interaction with other 
immune cells, mainly neutrophils and monocytes. As part of the first line of defense, 
neutrophils control invading pathogens by phagocytosis, the release of antimicrobial 
proteins during degranulation, or through the formation of web-like structures named 
neutrophil extracellular traps (NETs). NETs are formed by chromatin, proteases, and 
antimicrobial proteins, and their main function is to trap and kill bacteria, virus, and fungi, 
avoiding their dissemination. Besides microorganisms, NET formation is also triggered 
by proinflammatory molecules and platelets. The uncontrolled formation of NETs might 
exert tissue damage and has been involved in a pathogenic mechanism of autoimmune 
and prothrombotic clinical conditions. In this review, we discuss the role of platelets in 
NET generation highlighting the mediators, stimuli, and molecular mechanisms involved 
in this phenomenon, both in human and murine models.
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iNTRODUCTiON
Platelets are known to be central mediators of hemostasis and thrombosis; however, this role and 
the spatiotemporal relationship of the events that occur after tissue injury also link them directly 
to the host inflammatory and immune responses. The contribution of platelets to processes beyond 
hemostasis and thrombosis is associated with several properties, including the ability to store within 
intracellular granules – a broad array of biologically active molecules, which can be released into the 
circulation or translocated to the platelet surface during activation; and the recognition of pathogens 
through toll-like receptors (TLRs), and by the interaction of platelets directly with pathogens and 
other vascular cells, mainly endothelial cells and leukocytes (1).
Abbreviations: ADP, adenosine diphosphate; ALI, acute lung injury; ASA, acetylsalicylic acid; DNAse, deoxyribonuclease; 
DVT, deep vein thrombosis; GP, glycoprotein; GPCR, G-protein-coupled receptor; HMGB1, high mobility group box 1; 
LPS, lipopolysaccharide; MI, myocardial infarction; MPO, myeloperoxidase; NADPH, nicotinamide adenine dinucleotide 
phosphate; NETs, neutrophil extracellular traps; PAD4, peptidylarginine deiminase 4; PF4, platelet factor 4; PMA, phorbol-
12-myristate 13-acetate; PSGL-1, P-selectin glycoprotein ligand-1; ROS, reactive oxygen species; TLR, toll-like receptor; TRALI, 
transfusion-related acute lung injury; TXA2, thromboxane A2; VTE, venous thromboembolism; vWF, von Willebrand factor.
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The release of DNA extracellular traps is a newly discov-
ered defense mechanism of neutrophils in their fight against 
pathogen invasion. Neutrophil extracellular traps (NETs) occur 
as a result of a special cell death program named NETosis that 
involves the release of DNA webs decorated with all five types 
of histones and with neutrophil-derived granular proteins 
with antimicrobial activity, such as elastase, myeloperoxidase 
(MPO), and the bactericidal/permeability-increasing protein, 
among others (2). Even though these traps are important as 
anti-infection agents in the innate immune response, they can 
be a double-edged sword since, in excess, they are cytotoxic 
and induce tissue damage (3).
Increasing in vitro and in vivo evidence indicates that the abil-
ity of platelets to operate as innate immune cells is critical to the 
process of NET formation. In this review, we aim to discuss the 
role of platelets in the formation of NETs, identifying the stimuli, 
mediators, and molecular mechanisms involved as well as their 
physiopathologic relevance, both in mice and humans.
PLATeLeTS
Platelets are anucleated cells derived from megakaryocytes, 
which play a crucial role in hemostasis and thrombosis. Under 
normal conditions, circulating platelets do not adhere to the 
wall of blood vessels, leukocytes, or between them due to the 
anti-thrombotic properties of vascular endothelium. However, 
during vascular injury or after endothelium activation under 
inflammatory conditions, platelets adhere to subendothelial 
molecules such as collagen or von Willebrand factor (vWF), 
triggering initial platelet activation characterized by the release 
of soluble mediators stored in their granules, such as adeno-
sine diphosphate (ADP) and thromboxane A2 (TXA2). These 
molecules act as platelet activators amplifying cell activation 
in an autocrine manner and allowing the activation of other 
circulating platelets, favoring the formation of platelet–platelet 
aggregates. The interaction between platelets is called aggrega-
tion and occurs due to the principal integrin of these cells, αIIbβ3. 
Upon platelet activation, this integrin changes from a closed to 
an open conformation, enabling fibrinogen binding, which acts 
as a bridge between platelets. The amplification of platelet stimu-
lation leads to procoagulant activity, thrombin generation, and 
formation of a thrombus that will repair the damaged vessel (4).
NeUTROPHiL eXTRACeLLULAR TRAPS
The main function of NETs is to eliminate pathogens. Once 
attached to these webs, histones and microbicide proteins degrade 
virulence factors and kill pathogens. The NET is not only a trap, 
which prevents the propagation of pathogens from the initial site 
of infection, but also, by being attached to injurious stimuli, con-
centrates microbicide proteins to the site of infection (2). While 
NET formation was initially associated with pathogens such as 
bacteria, fungi, viruses, and parasites (5–9), it is now known that 
cytokines, chemokines, platelet agonists, and antibodies (10–14) 
are also capable of triggering this phenomenon. Depending on 
the location of the neutrophils when stimulated (extravasated 
versus vascular), these NETs can be either spread throughout 
the interstitium of specific organs or released into the lumen of 
blood vessels, where they may attach to the vessel walls of narrow 
capillaries.
NETosis is initiated by the activation of peptidylarginine 
deiminase 4 (PAD4), which induces citrulination of histones 
3 and 4 dismantling the nucleosome (15, 16). In addition, 
the activation of protein kinase C and nuclear factor kappa B 
(NFκB) pathways (12) and RAF/MEK/ERK signaling (17) leads 
to phosphorylation of several kinases resulting in assembly of 
the functional nicotinamide adenine dinucleotide phosphate 
(NADPH) oxidase complex for reactive oxygen species (ROS) 
generation (18). ROS trigger the dissociation of neutrophil 
elastase from a membrane-associated complex (azurosome) 
into the cytosol and activate its proteolytic activity in an MPO-
dependent manner. Once in the cytoplasm, elastase binds actin 
and is translocated to the nucleus where it promotes chromatin 
decondensation by cleavage of histones. After disintegration of 
the nuclear envelope and rupture of the cytoplasmic membrane, 
NETs are released (19, 20).
In addition to ROS generation, autophagy is also required 
for NET generation (21). Furthermore, recent evidence has also 
shown that activation of SK3 potassium channels, mediated by 
calcium influx, may lead to an alternative NADPH oxidase-
independent mechanism of NETosis (22).
The above description is of what is called “suicidal” NETosis 
(6). However, it has been reported that a fraction of neutrophils 
can release NETs without dying, leaving behind cytoplasts that 
continue to ingest microbes. This highly efficient process is called 
“vital” NETosis (23, 24).
NETs form an important arm of antimicrobial innate immu-
nity, which is exemplified by the fact that defects in NET genera-
tion, or experimental NET depletion, increase susceptibility to 
various kinds of infections in mice and humans (25–28).
ROLe OF PLATeLeTS iN NeT FORMATiON
Platelet involvement in DNA extracellular trap formation was first 
described in 2007, when Clark et al. showed in a mouse model of 
sepsis that lipopolysaccharide (LPS) binds to TLR4 present in the 
platelet membrane, allowing the binding of platelets to neutrophils 
and leading to rapid neutrophil activation and NET formation. 
These structures maintain their integrity under flow conditions 
and ensnare bacteria in the circulation (29). The finding that 
activation of TLR4 on platelets activates the release of NETs was 
a significant shift in understanding the inflammatory response to 
sepsis. The ability of platelets to promote NET formation was also 
observed in human cells, not only with Gram-negative bacterial 
components but also with Gram-positive bacteria (14).
Platelet-mediated NET formation is not restricted to activa-
tion by bacteria; it has been shown that platelets are also required 
for NETosis-mediated virus clearance. After systemic poxvirus 
challenge, mice exhibit thrombocytopenia and the recruitment of 
both neutrophils and platelets to the liver vasculature. Circulating 
platelets interact with, roll along, and adhere to the surface of 
adherent neutrophils, forming large aggregates that facilitate the 
release of NETs within the liver vasculature. Inhibition of this 
aggregation does not form NETs (30). The platelets’ participation 
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in the formation of NETs and virus clearance could represent 
another mechanism for the thrombocytopenia that is frequently 
observed in virus-infected patients (31). Although the central 
role of platelets in NETosis was initially identified in infectious 
processes, it also happens during sterile inflammation conditions. 
In fact, activation of platelets, not only by pathogens but also by 
classical platelet agonists such as thrombin, arachidonic acid, 
collagen, or ADP, results in NET induction (11, 13, 14, 32). These 
findings, together with the fact that besides exerting antimicro-
bial activity, NETs can also trigger procoagulant, prothrombotic, 
and proinflammatory responses and explain why NETs are 
increasingly being recognized as novel mediators of several non-
infectious clinical conditions, such as thrombosis, pre-eclampsia, 
and autoimmune diseases (3).
CeLL ADHeSiON MOLeCULeS iNvOLveD 
iN PLATeLeT-MeDiATeD NeTosis
Platelet–neutrophil interaction takes place mainly due to the 
binding of P-selectin to its receptor P-selectin glycoprotein 
ligand-1 (PSGL-1) on the leukocyte surface (33). Consistent with 
this observation, recent studies in mice have shown that NET 
formation during sepsis or acute lung injury (ALI) experimental 
models is also dependent on cell to cell interaction via PSGL-1 
and P-selectin (34, 35). However, other studies, including those 
from our group, have indicated that, in humans, platelet-mediated 
NET formation is a P-selectin-independent mechanism since its 
blockade does not modify DNA release and the incubation of 
neutrophils with recombinant P-selectin was not able to induce 
NETosis (13, 14). Platelet TLR4 appears to be a major target 
involved in platelet-mediated NETosis. As mentioned before, 
platelet TLR4 is involved in inducing NETs in mice and humans 
(14, 29). However, it is not yet known whether the LPS bound 
to platelet TLRs interacts with the neutrophils’ TLR4 counter 
receptor, or if it is just necessary to trigger platelet activation 
and the release of mediators that, in turn, induce NETosis. Of 
note, the blockade of platelet TLR4 markedly impairs NETosis 
and this has been suggested as a new therapeutic approach for 
sepsis (29).
Cooperation between neutrophil β2 integrin (CD18) and 
platelet glycoprotein (GP) Ib has been considered as another 
major event involved in platelet–neutrophil adhesion (36, 37). 
Studies using murine cells of wild type and mice deficient 
in CD18, as well as a murine model of sepsis, demonstrated 
that β2 integrin is also involved in platelet-mediated NETosis. 
Furthermore, blocking Mac-1 (CD18/CD11b), but not LFA-1 
(CD18/CD11a), in wild-type mice significantly reduced NET 
formation (38, 39). These data were corroborated in studies of 
mice and human cells where blocking CD18 markedly decreased 
the release of NETs mediated by activated platelets (14, 39). With 
regard to platelet GP Ib, its specific inhibition by gene deletion 
(40), or using blocking antibodies in human platelets (14), also 
affected the formation of NETs, demonstrating its participation 
in this process.
In a mouse model of ALI and using mice platelets and neu-
trophils, it has been shown that platelet-stimulated NETs require 
simultaneous activation of integrin-mediated outside-in and 
G-protein-coupled receptor (GPCR) signaling. Blocking one of 
these pathways reduced NET formation in vivo, diminishing the 
severity of ALI (39).
Platelet integrin αIIbβ3 is the most abundant molecule in the 
platelet’s surface that mediates interaction between platelets, 
and platelets with other cells. In a mouse model of lung injury, 
blocking the platelet integrin inhibited the formation of NETs and 
tissue damage (11), whereas a study of human platelets showed 
that αIIbβ3 seems not to participate in this process (13, 14).
Together, these observations suggest that the bridging between 
platelets and neutrophils in NET formation differs either between 
species or due to in  vivo cofactors not involved in the in  vitro 
models. In fact, while platelet-mediated NETosis in mice appears 
to be dependent on P-selectin, GPIb, TLR4, and integrin αIIbβ3 
expression on the platelet surface; human NET formation by 
platelets seems to only require GPIb and TLR4. In contrast, 
integrin β2 on the neutrophil’s surface appears to be a major 
protein involved in platelet-mediated NETosis, either in mice or 
humans.
SOLUBLe MeDiATORS OF PLATeLeT-
MeDiATeD NeTosis
Neutrophils and platelets activate each other. The crosstalk between 
these cells depends on cell-to-cell contact and secreted substances. 
Upon activation, platelets express or secrete vari ous molecules 
capable of modulating the activation of neutrophils (41).
High mobility group box 1 (HMGB1) is a damage-associated 
molecular pattern molecule, which is released as a result of cell 
death and represents a crucial sign in the inflammatory response 
to tissue injury (42). Platelets contain HMGB1, which is released 
after activation (43). Recently, it has been shown that platelet-
derived HMGB1 is a mediator of NET formation. Of interest, 
HMGB1, either soluble or presented from activated platelets, 
induces autophagy in neutrophils promoting NETosis and inhib-
iting apoptosis (13), supporting the notion that autophagy is a 
critical signal for the NETosis process. Of note, NETs induction 
by HMGB1 is independent of TLR4; thus, the axis HMGB1–
receptor for advanced glycation endproducts (RAGE) represents 
a potential target to control NET formation in sterile inflamma-
tory conditions.
Platelet-derived chemokines such as RANTES (CCL5) and 
platelet factor 4 (CXCL4, PF4) are well-known molecules respon-
sible for neutrophil recruitment to sites of inflammation/infec-
tion (44). In a mouse model of lung injury, it has been shown that 
blocking these cytokines or their heterodimerization inhibited 
NETosis (39). We have confirmed the participation of PF4 in 
NETosis using human cells, while inhibition of PF4 abrogated 
the release of DNA, recombinant PF4 promoted the formation 
of these DNA traps (14). These observations suggest that, besides 
chemotaxis, RANTES and PF4 are involved in the inflammatory 
response, not only recruiting leukocytes to the site of injury but 
also being strong NETs inducers.
Venous thromboembolism is a GP stored in α granules 
of megakaryocytes and platelet and Weibel Palade bodies of 
endothelial cells. After vessel injury, vWF mediates platelet 
adhesion to the exposed subendothelium (45). Several studies 
FiGURe 1 | Known molecules involved in platelet-mediated NeT formation. In humans (left), platelet activation induces thromboxane A2 (TXA2) formation, 
which triggers the release of high mobility group box 1 (HMGB1), von Willebrand factor (vWF), and platelet factor 4 (PF4). vWF binds to its platelet receptor, 
glycoprotein (GP)Ib, which binds to CD18 in neutrophils. PF4 and HMGB1 act directly upon neutrophils and induce DNA release. In mice, not only TXA2 generation 
and HMGB1 are involved but also PF4 and RANTES, through GPCR, induce platelet-mediated NET formation. Also, the interaction between P-selectin-PSGL-1 and 
αIIbβ3-Mac-1 is required for the release of NETs.
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have suggested that vWF is a critical component of NETs. In a 
murine model of deep vein thrombosis (DVT), it was observed 
that citrullinated histone H3 (citH3) colocalized with this factor, 
suggesting that this molecule and NETs form a network that con-
tributes to thrombus growth and stabilization (46). Furthermore, 
the ultralarge vWF fibers adhered to the endothelium that are 
observed during inflammation, bind and immobilize the DNA 
released by neutrophils acting as a linker between leukocyte adhe-
sion to the endothelium and supporting leukocyte extravasation 
and inflammation (47). In addition, we found that incubation of 
human platelets with an antibody against vWF suppressed NET 
formation induced by activated platelets, indicating that not only 
vWF is a NET inducer but also revealing a functional role for this 
molecule is released by platelets (14). Together, these observa-
tions indicate that, besides its function as an adhesive molecule, 
vWF secreted either by platelets or endothelial cells has a central 
role in the inflammatory and thrombotic features of NETs.
Thromboxane A2 is a potent platelet agonist, and its role 
in the formation of platelet-mediated NETs has been recently 
studied. In this context, it was reported that pharmacological 
inhibition of TXA2-mediated platelet activation by acetylsalicylic 
acid (ASA) suppressed the formation of platelet-mediated NET 
generation (11, 14). Furthermore, pretreatment of neutrophils 
with a selective thromboxane receptor antagonist (SQ29548) 
prior to the addition of thrombin receptor activating peptide 
(TRAP)-activated platelets reduced the production of NETs (11). 
The in vivo relevance of TXA2 in platelet-mediated NET forma-
tion was first pointed out by Caudrillier et  al. who showed in 
experimental transfusion-related acute lung injury (TRALI) that 
NETs are detectable in the lung microcirculation and they were 
prevented by inhibition of platelet aggregation using ASA (11). 
In addition, dipetalodipin and triplatin are triatomine salivary 
proteins that exhibit high affinity binding to prostanoids, such 
as TXA2, inhibited platelet-mediated NET formation (32). Given 
that neutrophils do not express the TXA2 receptor, the effect 
of TXA2 is intriguing. However, as TXA2 is a strong autocrine 
and paracrine activator, we have shown that this molecule, once 
released, acts on platelets triggering the release of platelet gran-
ules content, which in turn promote the formation of NETs (14) 
(Figure 1).
FiGURe 2 | Signaling pathways involved in platelet-mediated NeT 
formation. NETosis mediated by platelets requires activation of both human 
platelet and neutrophils ERK and Src kinases. In addition, PI3K signaling 
pathway in neutrophils is also required for NET formation. While NADPH 
oxidase in neutrophils is necessary to induce NET formation in mice, the 
signaling pathways in platelets are still not identified.
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SiGNALiNG iNvOLveD iN PLATeLeT-
MeDiATeD NeT FORMATiON
Although the molecular basis governing the formation of NETs 
are not yet fully elucidated, the activation of the RAF/MEK/
ERK, the generation of ROS by the enzyme NADPH oxidase, 
and activation of PAD4 seems to be of great importance in the 
NETosis induced by phorbol-12-myristate 13-acetate (PMA) 
(15–18). Phosphorylation of ERK both in platelets and neu-
trophils is also necessary for the formation of NETs mediated 
by activated platelets (11, 14, 48). Blocking ROS production, 
in both cell types, did not influence the release of DNA traps 
in human cells (14); however, in a murine model, NETosis was 
significantly decreased using diphenyleneiodonium (DPI) both 
in vitro and in vivo (39). Nevertheless, while platelet activation 
of Src is required for induction of platelet-mediated NETosis, in 
neutrophils both Src and PI3K activation are triggered during 
NET formation mediated by platelets (14, 48) (Figure 2). Further 
studies are required to elucidate the signaling pathways involved 
in platelet-mediated NETosis.
PLATeLeTS AND NeTs iN DiSeASe
infectious inflammation
Sepsis
It is increasingly recognized that platelets play an important role 
in the host defense to pathogens. Several mechanisms appear to 
be responsible for this response, including the ability of platelets 
to directly recognize, sequester, and kill pathogens, to recruit 
leukocytes to the site of infection and to activate neutrophils, 
enhancing their ability to phagocytose and kill pathogens (49). 
In addition, a seminal study by Clark et  al. (29) demonstrated 
that platelets induce neutrophil unique effector responses, such as 
the generation of NETs. In response to endotoxemia, neutrophils 
adhere to endothelium mainly in the sinusoids of the lungs and 
liver and then LPS-activated platelets anchor to the surface of 
neutrophils, promoting NETosis. Because these interactions 
were observed during severe sepsis, it was suggested that platelets, 
through the expression of TLR4, act as a barometer for systemic 
infection and, under high levels of LPS, the interplay between 
platelets and neutrophils constitutes an efficient mechanism 
in the fight against pathogens. Remarkably, the formation of 
NETs, if uncontrolled, is also responsible for tissue damage and 
organ dysfunction. The biological relevance of platelets in NET 
formation during sepsis was underscored by the observation that 
plasma from severely septic patients also triggered the formation 
of neutrophil DNA traps in the presence of platelets (29). In 
addition, in a Streptococcus mutans endocarditis rat model, it has 
been demonstrated that infective endocarditis-inducing patho-
gens activate platelets through specific IgG, which contributes to 
bacteria–platelet aggregate formation on the damaged valve; the 
bacteria also activate the infiltrated neutrophils and produce ROS, 
which triggers chromatin decondensation. The resulting NETs 
entrap the bacteria–platelets aggregates to promote vegetation 
formation (48). These observations lead the authors to suggest 
that a similar process could take place in human endocarditis, 
because NETs have been identified in human specimens.
Interestingly, it was recently proposed that the link between 
 coagulation and the innate immune response might constitute an 
innate effector mechanism, named immunothrombosis, which 
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deoxyribonuclease (DNAse), indicating that NETs may provide 
a scaffold independent from fibrin (53).
Using a mouse model of flow restriction-induced DVT, von 
Bruhl et  al. and Brill et  al. demonstrated that flow restriction 
triggers the rapid accumulation of leukocytes, mainly neu-
trophils (85%) and monocytes (15%), that initiate local fibrin 
formation through the expression of tissue factor. In addition, 
neutrophils form NETs that bind factor XII and initiate coagula-
tion. Platelets were critical to foster neutrophil recruitment and 
NET formation through the GPIb-β2 integrin axis and supported 
fibrin formation by enhancing neutrophil-dependent coagula-
tion. While DNAse I and enoxaparin protected mice from DVT, 
infusion of an unfractionated mixture of calf thymus histones 
increased plasma vWF and promoted DVT early after stenosis 
application, indicating the relevant role of NETs in DVT (40, 
46). In fact, these experimental models provided the first in vivo 
evidence that NETs can act as a platform for thrombogenesis 
in large veins in response to perturbations of flow and also that 
these DNA traps are a unique link between inflammation and 
DVT. Furthermore, these studies highlighted that platelets, com-
monly recognized as central mediators of arterial thrombosis, 
also contribute to inflammation and the propagation of DVT 
in the absence of endothelial disruption, mainly fostering NET 
formation.
The critical role of NETs in developing DVT was also demon-
strated by Martinod et al., who showed that PAD4-deficient mice 
(PAD4−/−) were protected from producing venous thrombi (57). 
However, in contrast to these observations, El-Sayed et al. found 
no differences in the stasis thrombus size either in WT animals 
that were treated with DNAse I or in PAD4−/− mice compared 
with controls (58). The differences between these studies are 
still not clear and require further investigation. Furthermore, 
unexpectedly, it was recently reported that neutrophils from 
elastase-deficient mice only showed a mild reduction in non-
infectious stimuli-mediated NET formation in vitro and accord-
ingly, elastase deficiency had no significant effect on thrombosis 
in the inferior vena cava stenosis model (59). These data revealed 
not only that neutrophil elastase is not essential for NETosis 
but also that even partial NET release seems sufficient to attract 
platelets, red blood cells, promote coagulation, and drive venous 
thrombus formation. Since all these findings were obtained in 
mice, the question arises whether similar molecular mechanisms 
are effective in humans.
The first clinical study of 150 patients showed that increased 
levels of circulating nucleosomes and neutrophil activation, as 
evidenced by the presence of elastase–antitripsin complexes, 
were associated with a threefold risk of DVT (60). In another 
study, immunohistochemical analysis of thrombi obtained from 
patients at different stages of VTE demonstrated the presence of 
NETs during the organizing stage of thrombus maturation. In 
contrast, NETosis was absent in the mature regions of organized 
thrombi. CitH3-positive cells surrounded vWF-positive platelet 
islands in human DVT samples, and diffuse vWF-positive stain-
ing was associated with diffuse citH3 patterns in the organizing 
regions of thrombi (61). These findings support the notion that 
NETs, together with vWF, could enhance thrombus formation/
stability in DVT.
mediates the recognition of pathogens and damaged cells and 
inhibits pathogen dissemination and survival. Immunothrombosis 
is therefore considered to be a physiological process crucial for 
intravascular immunity, whereas its dysregulation may be one of 
the underlying events that trigger thrombotic disorders, such as 
VTE and disseminated intravascular coagulation. Neutrophils are 
major players in the development of immunothrombosis through 
the release of NETs. Moreover, NETs may also provide a scaffold 
to activate platelets and stimulate thrombus formation (50). 
Several studies have indicated the relationship between infection 
and thrombosis; however, the pathogenic mechanism was not 
clear. The discovery of NETs and the bidirectional interaction 
with platelets represents a link between these phenomena.
Sterile inflammation
Acute Lung Injury
In a murine model of TRALI, NETs were found in the micro-
circulation of the lungs and components of these networks in 
plasma (11). When platelet function was inhibited, DNA content 
significantly decreased indicating that platelets are necessary 
for the generation of NETs. Similar results were demonstrated 
in a mouse model of ventilation-induced lung injury (39). In 
this study, platelet depletion resulted in a decreased neutrophil 
accumulation in alveolar compartments and release of these 
DNA traps. Furthermore, a similar result was obtained by 
specifically inhibiting the heterodimerization of RANTES and 
PF4, reaffirming the role of platelets in this mechanism, and 
increasing the severity of the disease. However, Thomas et  al. 
reported that platelet depletion with neuraminidase in a murine 
model of TRALI did not prevent NET formation in the lungs 
(51). This observation was only qualitative, thus, it is conceivable 
that platelets potentiate the release of NETs induced by other 
agonists. Taking into account these discrepancies, more studies 
are needed to understand the relevance of platelets in the forma-
tion of NETs in TRALI and whether therapeutic inhibition of 
platelet–neutrophil aggregates and/or NET formation provide a 
useful therapeutic strategy.
Thrombosis
Venous Thrombosis
Traditionally, the pathogenic mechanism of venous thromboem-
bolism (VTE) that includes DVT or pulmonary embolism was 
considered the result of reduction in blood flow, injury to the vas-
cular endothelium and a hypercoagulable state (Virchow’s Triad) 
(52). The discovery of NETs offered a very exciting explanation 
for the cellular events that trigger VTE. Initial studies showed that 
DNA traps promote platelet adhesion, activation, and aggrega-
tion and exert procoagulant activity, thus providing a scaffold for 
thrombus formation and growth (53). These effects are mainly 
caused by histones present in the NETs (54–56). Moreover, his-
tones induce the release of platelet mediators that, in turn, induce 
NETosis, thus creating a positive feedback mechanism that 
favors thrombus formation. NETs also recruit red blood cells and 
promote vWF, fibrinogen, and fibrin deposition inducing a red 
thrombus, such as that found in veins. Remarkably, clot formation 
in the presence of activated neutrophils can be prevented only by 
simultaneous treatment with tissue plasminogen activator and 
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Arterial Thrombosis
Increased levels of nucleosomes and cell-free DNA have frequently 
been shown to be associated with infarcted tissue in patients with 
ischemic stroke and myocardial infarction (MI) (62). However, 
because these biomarkers are not specific to tissue injury, it was not 
clear from these studies whether the DNA material was released 
from necrotic tissues or from NETs. Furthermore, the relationship 
was not established between the nucleosome of cell-free DNA 
and thrombi. The presence of citH3 neutrophils in heart sections 
and increased plasma nucleosomes levels in mice subjected to 
myocardial reperfusion injury was recently demonstrated. Also 
of note, monotherapy with DNAse I significantly decreased the 
number of infiltrating neutrophils and plasma nucleosomes levels 
as well as reducing the infarcted area and improving cardiac func-
tion, indicating not only that NETs are components of the inflam-
matory milieu of the infarcted myocardium but also their direct 
involvement in cardiac injury (63). In a prospective, observational, 
cross-sectional cohort of 282 individuals with suspected coronary 
artery disease, Borissoff et al. found that markers of NETs, such as 
MPO–DNA complexes, predicted the number of atherosclerotic 
coronary vessels, the presence of a hypercoagulable state, and 
the occurrence of major adverse cardiac events (64). Moreover, 
they also identified high nucleosome levels as an independent 
risk factor of severe coronary stenosis. Of note, this study only 
found a weak correlation of platelet activation markers (measured 
by PF4 plasmatic levels) and citH4 levels. However, in another 
study, Maugeri et al. demonstrated that in patients with acute MI, 
coronary artery thrombi obtained during percutaneous coronary 
intervention were made up mainly of platelets and neutrophils 
and contained large amounts of DNA strands that were decorated 
with citrullinated histones and granule proteins such as MPO and 
pentraxin; platelets were identified close to DNA webs (13). In 
support of these observations, citH3 was detected in the cerebral 
microthromboses of ischemic stroke patients. Interestingly, 
the patients also had an unexpectedly higher prevalence of 
cancer; half of the cancers were diagnosed post-mortem (65). 
Furthermore, cancer patients had increased plasmatic markers of 
NETosis that correlated positively with thrombin–antithrombin 
levels and soluble P-selectin. These data not only further support 
the link between NETosis and thrombosis but also highlight the 
relevance of NET formation as biomarkers detecting cancer in 
arterial microthrombosis, or vice versa.
The role of NETs and platelets was also confirmed in patients 
with MI in selective samplings of thrombotic material and sur-
rounding blood from the infarct-related coronary artery during 
primary percutaneous revascularization. The study showed that 
interaction of thrombin-activated platelets with neutrophils at 
the site of plaque rupture during an acute MI results in local NET 
formation and delivery of functional tissue factor (66).
CONCLUSiON
The presented evidence indicates that platelets, when stimulated 
by bacteria, viruses, or traditional agonists, are capable of binding 
to neutrophils, activating them to release NETs. This interaction 
can be beneficial to protect the host against pathogens but, 
if uncontrolled, can cause tissue and organ damage. Of note, 
while experiments performed in  vitro are compelling in their 
collective confirmation that platelet–neutrophil interactions can 
be induced to generate NETs, the relevance of this interaction 
in vivo still contains elements of ambiguity and leads to numerous 
unresolved questions often involving pathway differences, both 
between species and cell types.
The interaction of platelets and neutrophils in NETosis 
induction appears to be a relevant pathogenic mechanism for 
both arterial and venous thrombosis; prevention of platelet- and 
neutrophil-mediated thrombogenesis is now being considered as 
a potential promising new target for anti-thrombotic therapy.
Although we have witnessed great advances during the last 
decade in the comprehension of NETosis and the involvement 
of platelets in this process, several questions still remain to be 
answered: are circulating nucleosomes and activated neutrophils 
causative of thrombus formation or are they rather a consequence 
of its development? Is there any degree of selectivity regarding the 
decondensation and release of DNA during NETosis mediated by 
platelets in sterile or infectious conditions? Is there any relation-
ship between platelets and NETs formation in atherosclerotic 
plaque progression? Is NETosis mediated by platelets required 
for hemostasis?
It is clear that more experimental and clinical studies are 
required to further understand the physiopathologic relevance 
of this newly discovered interaction between platelets and 
neutrophils.
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